# Osisko Gold Group Inc.: overview

OGG · NYSE · CIK 1431852 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ogg.md) · [Financials](/companies/ogg/financials.md) · [Filings](/companies/ogg/filings.md) · [Insiders](/companies/ogg/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7.7](/filings/0001104659-23-040419.md) | [64.0](/filings/0001558370-24-004310.md) | [31.6](/filings/0001558370-25-004047.md) | [4.6](/filings/0001104659-26-036344.md) | [35.5](/filings/0001104659-26-036344.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(2054.1%)](/filings/0001104659-23-040419.md) | [(365.8%)](/filings/0001558370-24-004310.md) | [(662.3%)](/filings/0001558370-25-004047.md) | [(1368.2%)](/filings/0001104659-26-036344.md) | [(230.4%)](/filings/0001104659-26-036344.md) |
| Net margin | % | [(1740.0%)](/filings/0001104659-23-040419.md) | [(300.5%)](/filings/0001558370-24-004310.md) | [(575.1%)](/filings/0001558370-25-004047.md) | [(1893.5%)](/filings/0001104659-26-036344.md) | [(476.4%)](/filings/0001104659-26-036344.md) |
| Diluted EPS | $ per share | [(3.03)](/filings/0001104659-23-040419.md) | [(3.02)](/filings/0001558370-24-004310.md) | [(2.21)](/filings/0001558370-25-004047.md) | [(0.92)](/filings/0001104659-26-036344.md) | [(0.95)](/filings/0001104659-26-036344.md) |
| Free cash flow | $m | [(88.9)](/filings/0001104659-23-040419.md) | [(79.7)](/filings/0001558370-24-004310.md) | [(61.3)](/filings/0001558370-25-004047.md) | [(88.6)](/filings/0001104659-26-036344.md) | [(121)](/filings/0001104659-26-036344.md) |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ogg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $1.1m | 430,613 |  | New +430,613 |

## Recent filings

[All 244 filings](/companies/ogg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 07:00 ET | [6-K](/filings/0001171843-26-006836.md) | Report of a foreign private issuer, period 2026-10-27 | 0001171843-26-006836 |
| 2026-10-09 | 14:14 ET | [6-K](/filings/0001171843-26-006561.md) | Report of a foreign private issuer, period 2026-10-09 | 0001171843-26-006561 |
| 2026-10-05 | 08:00 ET | [6-K](/filings/0001171843-26-006384.md) | Report of a foreign private issuer, period 2026-10-05 | 0001171843-26-006384 |
| 2026-10-01 | 17:00 ET | [6-K](/filings/0001171843-26-006338.md) | Report of a foreign private issuer, period 2026-10-01 | 0001171843-26-006338 |
| 2026-09-30 | 17:11 ET | [6-K](/filings/0001104659-26-112403.md) | Report of a foreign private issuer, period 2026-09-30 | 0001104659-26-112403 |
| 2026-09-23 | 07:00 ET | [6-K](/filings/0001171843-26-006180.md) | Report of a foreign private issuer, period 2026-09-23 | 0001171843-26-006180 |
| 2026-09-14 | 07:00 ET | [6-K](/filings/0001171843-26-006024.md) | Report of a foreign private issuer, period 2026-09-14 | 0001171843-26-006024 |
| 2026-08-25 | 17:15 ET | [6-K](/filings/0001171843-26-005737.md) | Report of a foreign private issuer, period 2026-08-25 | 0001171843-26-005737 |
| 2026-08-20 | 17:00 ET | [6-K](/filings/0001171843-26-005689.md) | Report of a foreign private issuer, period 2026-08-20 | 0001171843-26-005689 |
| 2026-08-14 | 18:35 ET | [6-K](/filings/0001171843-26-005508.md) | Report of a foreign private issuer, period 2026-08-13 | 0001171843-26-005508 |

## Latest annual report

[Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-036344.md), filed Mar 30, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1431852
- Tickers: OGG, OGGWZ, OSDVF
- Exchange: NYSE
- SIC code: 1040 Gold and Silver Ores
- State of incorporation: Z4
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:30 ET. No prices; not investment advice.
